Oxbridge Clinical is creating innovative technologies for point-of-care, germ-specific diagnosis and antibiograms.
Oxbridge Clinical has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Oxbridge Clinical's investors include BioTools Innovator.
Oxbridge Clinical is headquartered in Boston, United States.
Oxbridge Clinical is creating innovative technologies for point-of-care, germ-specific diagnosis and antibiograms.
Oxbridge Clinical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oxbridge Clinical — Funding & Investors." VCBacked, October 31, 2025, https://www.vcbacked.co/company/oxbridge-clinical. Accessed August 14, 2026.
VCBacked. (2025). Oxbridge Clinical — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oxbridge-clinical
{{cite web |title=Oxbridge Clinical — Funding & Investors |url=https://www.vcbacked.co/company/oxbridge-clinical |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated